Fecal Incontinence: Clinical Trials

11 trials for Fecal Incontinence, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed. 11 Phase 2, 5 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 211Completed 11
Phase 15Completed 5
Phase 32Completed 2

Follow Fecal Incontinence: new trials by email Literature Review of Fecal Incontinence trials Research Report on Fecal Incontinence

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Lidocaine Patches Prior to Percutaneous Nerve Evaluation
Lidocaine patch, Placebo - Overactive Bladder, Urge Incontinence
Phase 2CompletedUniversity of Louisville392023-05-012025-02-03
The Effect of Oxymetazoline Gel on Anal Pressure and Incontinence in Spinal Cord Injury Patients
Oxymetazoline gel, Placebo gel - Fecal Incontinence, Spinal Cord Injury
Phase 1 / Phase 2CompletedRDD Pharma Ltd192014-11-012015-07-28
Comparing the Effectiveness of Two Dietary Interventions for Fecal Incontinence
low fodmap diet, Psyllium - Fecal Incontinence
Phase 2CompletedUniversity of Michigan402014-10-022019-08-28
Autologous Cell Therapy for Treatment of Fecal Incontinence
Iltamiocel - Fecal Incontinence
Phase 1 / Phase 2CompletedCook MyoSite532013-03-282024-02-16
Autologous Myoblast Intrasphincteric Injection for Fecal Incontinence
Myoblast injection, saline solution injection - Fecal Incontinence
Phase 2 / Phase 3CompletedUniversity Hospital, Rouen242012-02-012015-10-23
An Study to Examine the Effect of Coated Suppositories on Anal Pressure in Healthy Subjects
coated suppository - Fecal Incontinence
Phase 1 / Phase 2CompletedRDD Pharma Ltd62011-08-012011-08-23
Percutaneous Tibial Nerve Stimulation for the Treatment of Fecal Incontinence
active stimulation, sham stimulation - Fecal Incontinence
Phase 2CompletedUniversity Hospital, Rouen1442009-10-012011-08-23
A Placebo-Controlled Study of Clonidine for Fecal Incontinence.
Clonidine, Placebo - Fecal Incontinence
Phase 2CompletedMayo Clinic442008-10-012014-03-06
Efficacy and Mechanisms of Pharmacologic Treatment of Fecal Incontinence
Psyllium powder, Loperamide - Fecal Incontinence
Phase 2 / Phase 3CompletedUS Department of Veterans Affairs802008-07-012015-04-01
Evaluation of Outcomes of Restoring Pelvic Floor Support With TOPAS in Women With Moderate Fecal Incontinence Symptoms
TOPAS - Fecal Incontinence
Phase 1 / Phase 2CompletedASTORA Women's Health292007-09-012016-05-23
Safety and Efficacy of Anorectal Application of Dx-gel for Treatment of Anal Incontinence
Anal injection of Nasha Dx - Fecal Incontinence
Phase 1 / Phase 2CompletedUppsala University Hospital352004-02-012011-06-28

Narrower conditions

Diarrhea (1)  ·  Encopresis (1)  ·  Gastrointestinal Diseases (1)  ·  Intestinal Diseases (1)  ·  Rectal Diseases (1)  ·  Spinal Cord Injuries (1)  ·  Urinary Bladder, Overactive (1)  ·  Urinary Incontinence (1)  ·  Urinary Incontinence, Urge (1)

Broader conditions

Digestive System Diseases (11)  ·  Gastrointestinal Diseases (10)  ·  Intestinal Diseases (10)  ·  Rectal Diseases (10)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Signs and Symptoms (3)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Lower Urinary Tract Symptoms (2)  ·  Male Urogenital Diseases (2)  ·  Signs and Symptoms, Digestive (2)  ·  Urination Disorders (2)  ·  Urogenital Diseases (2)  ·  Urologic Diseases (2)  ·  Urological Manifestations (2)

Interventions

Psyllium (2)  ·  Clonidine (1)  ·  FODMAP Diet (1)  ·  Loperamide (1)  ·  Saline Solution (1)  ·  dextranomer-hyaluronic acid copolymer (1)

Sponsors

RDD Pharma Ltd (2)  ·  University Hospital, Rouen (2)  ·  ASTORA Women's Health (1)  ·  Cook MyoSite (1)  ·  Mayo Clinic (1)  ·  US Department of Veterans Affairs (1)  ·  University of Louisville (1)  ·  University of Michigan (1)  ·  Uppsala University Hospital (1)

Countries

United States (5)  ·  France (2)  ·  Canada (1)  ·  Hungary (1)  ·  Israel (1)  ·  Sweden (1)  ·  United Kingdom (1)

Top investigators

Adil E Bharucha, M.D. (1)  ·  Alayne D Markland, DO MSc (1)  ·  Anders Mellgren, MD, PhD (1)  ·  Manoj J Raval, MD (1)  ·  Michael Shapiro, MD (1)  ·  Stacy B Menees, MD (1)  ·  Wilhelm JR Graf, Prof. (1)

Results publications

PMID 19581853, PMID 23891925, PMID 24763157, PMID 25565635, PMID 35060943, PMID 37144409, PMID 40013530

NIH funding

R01DK078924 (1), UL1RR024150 (1)